To sum up, LP45 can exert its antioxidant effect by inhibiting the production of oxidative stress to activate the SHP2 signaling pathway, thus promoting osteoblast differentiation and repressing osteoclast formation to maintain bone homeostasis and improve bone metabolism, which offers a new idea and approach for the prevention and treatment of osteoporosis. This evidence concerns the gene PTPN11 and osteoporosis.